Infantile Epileptic Spasm Syndrome (IESS) is a quite rare epileptic encephalopathy that occurs within the first two years of life, and manifesting with epileptic spams usually in cluster, electroencephalographic anomaly mostly hypsarrhythmia pattern, and developmental arrest or regression. IESS are etiologically classified in symptomatic and cryptogenic. Nowadays there is no general agreement on the treatment of the IESS as hormonal therapy, oral steroid, ketogenic diet and modified Atkins, pyridoxine, anticonvulsants drugs including vigabatrin (VBG), valproate, levetiracetam, topiramate, and benzodiazepines have been proposed to be used individually, sequentially, or in combination ( 1) ). Prompt diagnosis and appropriate treatment in IESS are maintained useful to improve the cognitive course of the disorder. As known, the IESS outcome is related to etiological factors and to precocious treatment ( 2) ).

Real-life data comparing the efficacy of vigabatrin and oral steroids given sequentially or combined for infantile epileptic spasms syndrome

Raffaele, Falsaperla
Ultimo
2024

Abstract

Infantile Epileptic Spasm Syndrome (IESS) is a quite rare epileptic encephalopathy that occurs within the first two years of life, and manifesting with epileptic spams usually in cluster, electroencephalographic anomaly mostly hypsarrhythmia pattern, and developmental arrest or regression. IESS are etiologically classified in symptomatic and cryptogenic. Nowadays there is no general agreement on the treatment of the IESS as hormonal therapy, oral steroid, ketogenic diet and modified Atkins, pyridoxine, anticonvulsants drugs including vigabatrin (VBG), valproate, levetiracetam, topiramate, and benzodiazepines have been proposed to be used individually, sequentially, or in combination ( 1) ). Prompt diagnosis and appropriate treatment in IESS are maintained useful to improve the cognitive course of the disorder. As known, the IESS outcome is related to etiological factors and to precocious treatment ( 2) ).
2024
Pavone, Piero; Falsaperla, Raffaele
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S109037982400014X-main.pdf

accesso aperto

Tipologia: Pre-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 627.55 kB
Formato Adobe PDF
627.55 kB Adobe PDF Visualizza/Apri
1-s2.0-S109037982400014X-main.pdf

solo gestori archivio

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 248.21 kB
Formato Adobe PDF
248.21 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2538493
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 3
social impact